A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States.

ABSTRACT:

Introduction

The COVID-19 pandemic is a global crisis impacting population health and the economy. We describe a cost-effectiveness framework for evaluating acute treatments for hospitalized patients with COVID-19, considering a broad spectrum of potential treatment profiles and perspectives within the US healthcare system to ensure incorporation of the most relevant clinical parameters, given evidence currently available.

Methods

A lifetime model, with a short-term acute care decision tree followed by a post-discharge three-state Markov cohort model, was developed to estimate the impact of a potential treatment relative to best supportive care (BSC) for patients hospitalized with COVID-19. The model included information on costs and resources across inpatient levels of care

SUBMITTER: Sheinson D 

PROVIDER: S-EPMC7919620 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature